Accelerating Therapeutic DiscoveryTM

News From The Alpha-1 Project

Entries for April 2019

05
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for an adaptive Phase 2/3 trial with t...

[Read More...]